Compare HUBB & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUBB | DGX |
|---|---|---|
| Founded | 1888 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.4B | 23.2B |
| IPO Year | 2004 | 1996 |
| Metric | HUBB | DGX |
|---|---|---|
| Price | $484.63 | $236.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | ★ $517.88 | $214.38 |
| AVG Volume (30 Days) | 500.4K | ★ 994.0K |
| Earning Date | 04-30-2026 | 04-21-2026 |
| Dividend Yield | 1.04% | ★ 1.82% |
| EPS Growth | ★ 15.10 | 13.78 |
| EPS | 3.41 | ★ 5.08 |
| Revenue | $5,844,600,000.00 | ★ $11,035,000,000.00 |
| Revenue This Year | $10.41 | $7.53 |
| Revenue Next Year | $5.49 | $3.77 |
| P/E Ratio | $146.23 | ★ $45.64 |
| Revenue Growth | 3.84 | ★ 11.78 |
| 52 Week Low | $403.82 | $166.75 |
| 52 Week High | $565.50 | $237.78 |
| Indicator | HUBB | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 47.25 | 76.83 |
| Support Level | $462.95 | $190.42 |
| Resistance Level | $491.11 | N/A |
| Average True Range (ATR) | 16.22 | 6.73 |
| MACD | 0.48 | 2.57 |
| Stochastic Oscillator | 56.97 | 89.99 |
Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, in electrical substations, and in commercial and industrial buildings. The company's primary operations are in the United States, where around 90% of revenue is derived.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.